Document is current
Any future updates will be listed below
-
Authors
- License Information
-
More Information
Article History
First Online: 31 July 2025
Competing interests
: C.K.A. has consulted with Genentech, Eisai, IPSEN, Seattle Genetics, Astra Zeneca, Novartis, Immunomedics, Elucida, Athenex, and Roche; she has received research funding from PUMA, Lilly, Merck, Seattle Genetics, Nektar, Tesaro, G1-Therapeutics, ZION, Novartis, Pfizer, Astra Zeneca, Elucida, Caris, Incyclix, Beigene and royalties from UptoDate.com and Jones and Bartlett. R.B. has consulted with NCODA, CareSpace Health Inc, Onviv; she has received research funding from AstraZeneca, Sermonix, Gilead, Jazz Pharmaceuticals and Genentech. A.E.D.V. has no conflicts to disclose.
